Ask Warren

CJ Bioscience

311690 · KOSDAQ · ₩311690 · CJ 바이오사이언스

₩3,695▲ ₩5 (0.14%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩898M₩783M₩1.3B₩738M₩784M₩913M₩941M₩744M
Cost of sales₩686M₩633M₩898M₩675M₩700M₩720M₩787M₩747M
Gross profit₩212M₩150M₩360M₩63M₩83M₩193M₩154M−₩3.1M
Operating income−₩6.4B−₩5.3B−₩5.2B−₩6.1B−₩7B−₩6.6B−₩9.8B−₩8.6B
Net income−₩1.1B−₩5.1B−₩18B₩1.1B−₩756M−₩6.1B−₩25B−₩532M
Net income to shareholders−₩6.2B−₩5.1B−₩5.2B−₩5.8B−₩6.9B−₩6.1B−₩9.5B−₩8.3B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩60B₩65B₩72B₩76B₩82B₩89B₩100B₩67B
Current assets₩43B₩46B₩52B₩58B₩63B₩67B₩77B₩44B
Cash and equivalents₩4.6B₩2.1B₩10B₩2.8B₩13B₩3.5B₩8.3B₩42B
Total liabilities₩19B₩17B₩19B₩17B₩17B₩17B₩22B₩19B
Current liabilities₩15B₩13B₩15B₩15B₩14B₩14B₩19B₩14B
Borrowings₩7.9B₩7.5B₩7B₩6.5B₩6.2B₩6.5B₩6.4B₩5.1B
Total equity₩42B₩48B₩54B₩59B₩65B₩72B₩78B₩48B
Shareholders' equity₩42B₩48B₩54B₩59B₩65B₩72B₩78B₩48B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩3.7B−₩6.3B−₩4.7B−₩5.1B−₩3.8B−₩9.8B−₩6.8B−₩6.9B
Capital spending——₩7.8M₩0——₩154M₩224M
Free cash flow−₩3.7B−₩6.3B−₩4.7B−₩5.1B−₩3.8B−₩9.8B−₩6.9B−₩7.1B

Consolidated where available. Amounts in won.

Also known as: CJ Bioscience / CJ 바이오사이언스 / 311690 / KRX:311690

Source: KRX statistical information